Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial
Bretzel, Reinhard G, Prof, Nuber, Ulrike, PhD, Landgraf, Wolfgang, PhD, Owens, David R, Prof, Bradley, Clare, Prof, Linn, Thomas, Prof
Published in The Lancet (British edition) (29.03.2008)
Published in The Lancet (British edition) (29.03.2008)
Get full text
Journal Article
The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL
Hanefeld, Markolf, Traylor, Louise, Gao, Ling, Landgraf, Wolfgang
Published in Cardiovascular diabetology (19.05.2017)
Published in Cardiovascular diabetology (19.05.2017)
Get full text
Journal Article
Initiating Insulin Therapy in Type 2 Diabetic Patients Failing on Oral Hypoglycemic Agents
Bretzel, Reinhard G., Eckhard, Michael, Landgraf, Wolfgang, Owens, David R., Linn, Thomas
Published in Diabetes care (01.11.2009)
Published in Diabetes care (01.11.2009)
Get full text
Journal Article
Treatment responses to basal insulin glargine 300U/ml and glargine 100U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
Landgraf, Wolfgang, Owens, David R, Frier, Brian M, Bolli, Geremia B
Published in Diabetes, obesity & metabolism (01.02.2024)
Published in Diabetes, obesity & metabolism (01.02.2024)
Get full text
Journal Article
Treatment responses to basal insulin glargine 300 U/ml and glargine 100 U/ml in newly defined subphenotypes of type 2 diabetes: A post hoc analysis of the EDITION 3 randomized clinical trial
Landgraf, Wolfgang, Owens, David R., Frier, Brian M., Bolli, Geremia B.
Published in Diabetes, obesity & metabolism (01.02.2024)
Published in Diabetes, obesity & metabolism (01.02.2024)
Get full text
Journal Article
Patient-level meta-analysis of efficacy and hypoglycaemia in people with type 2 diabetes initiating insulin glargine 100 U/mL or neutral protamine Hagedorn insulin analysed according to concomitant oral antidiabetes therapy
Owens, David R, Traylor, Louise, Mullins, Peter, Landgraf, Wolfgang
Published in Diabetes research and clinical practice (01.02.2017)
Published in Diabetes research and clinical practice (01.02.2017)
Get full text
Journal Article
Hypoglycaemia risk with insulin glargine 300U/mL compared with glargine 100U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
Bolli, Geremia B, Landgraf, Wolfgang, Bosnyak, Zsolt, Lydie Melas‐Melt, Home, Philip D
Published in Diabetes, obesity & metabolism (01.09.2020)
Published in Diabetes, obesity & metabolism (01.09.2020)
Get full text
Journal Article
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100U/mL
Landgraf, Wolfgang, Owens, David R, Frier, Brian M, Zhang, Mei, Bolli, Geremia B
Published in Diabetes, obesity & metabolism (01.03.2020)
Published in Diabetes, obesity & metabolism (01.03.2020)
Get full text
Journal Article
Fasting C‐peptide, a biomarker for hypoglycaemia risk in insulin‐naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL
Landgraf, Wolfgang, Owens, David R., Frier, Brian M., Zhang, Mei, Bolli, Geremia B.
Published in Diabetes, obesity & metabolism (01.03.2020)
Published in Diabetes, obesity & metabolism (01.03.2020)
Get full text
Journal Article
Comparative efficacy and safety of Gla‐300 versus IDegAsp in insulin‐naïve people with type 2 diabetes mellitus uncontrolled on oral anti‐diabetics
Ritzel, Robert, Ghosh, Sujoy, Emral, Rifat, Malek, Rachid, Zeng, Longyi, Mabunay, Maria Aileen, Landgraf, Wolfgang, Guyot, Patricia, Serafini, Paul, Pushkarna, Divya, Malik, Rayaz A.
Published in Diabetes, obesity & metabolism (01.09.2023)
Published in Diabetes, obesity & metabolism (01.09.2023)
Get full text
Journal Article
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis
Landgraf, Wolfgang, Owens, David R., Frier, Brian M., Bolli, Geremia B.
Published in Diabetes therapy (01.08.2024)
Published in Diabetes therapy (01.08.2024)
Get full text
Journal Article
Efficacy and safety of basal insulin glargine 12 and 24 weeks after initiation in persons with type 2 diabetes: A pooled analysis of data from treatment arms of 15 treat-to-target randomised controlled trials
Owens, David R, Traylor, Louise, Dain, Marie-Paule, Landgraf, Wolfgang
Published in Diabetes research and clinical practice (01.11.2014)
Published in Diabetes research and clinical practice (01.11.2014)
Get full text
Journal Article
Distribution and characteristics of newly-defined subgroups of type 2 diabetes in randomised clinical trials: Post hoc cluster assignment analysis of over 12,000 study participants
Landgraf, Wolfgang, Bigot, Gregory, Hess, Sibylle, Asplund, Olof, Groop, Leif, Ahlqvist, Emma, Käräjämäki, Annemari, Owens, David R., Frier, Brian M., Bolli, Geremia B.
Published in Diabetes research and clinical practice (01.08.2022)
Published in Diabetes research and clinical practice (01.08.2022)
Get full text
Journal Article
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trial
Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.
Published in Diabetes, obesity & metabolism (01.09.2020)
Published in Diabetes, obesity & metabolism (01.09.2020)
Get full text
Journal Article
High Levels of Baseline HbA1c, FPG, and 2-Hour Postprandial Glucose Are Key Predictors for Not Achieving HbA1c < 7.0% at Six Months in People with T2DM Starting Insulin Glargine 100 U/mL
OWENS, DAVID R., LANDGRAF, WOLFGANG, ZHANG, MEI, FRIER, BRIAN M., MENEGHINI, LUIGI, HOME, PHILIP, BOLLI, GEREMIA B.
Published in Diabetes (New York, N.Y.) (01.07.2018)
Published in Diabetes (New York, N.Y.) (01.07.2018)
Get full text
Journal Article
Response to insulin glargine 100 U/mL treatment in newly-defined subgroups of type 2 diabetes: Post hoc pooled analysis of insulin-naïve participants from nine randomised clinical trials
Landgraf, Wolfgang, Bigot, Gregory, Frier, Brian M., Bolli, Geremia B., Owens, David R.
Published in Primary care diabetes (01.08.2023)
Published in Primary care diabetes (01.08.2023)
Get full text
Journal Article
Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0
Owens, David R., Landgraf, Wolfgang, Frier, Brian M., Zhang, Mei, Home, Philip D., Meneghini, Luigi, Bolli, Geremia B.
Published in Diabetes, obesity & metabolism (01.02.2019)
Published in Diabetes, obesity & metabolism (01.02.2019)
Get full text
Journal Article
Glycaemic responses in Asian and non-Asian people with type 2 diabetes initiating insulin glargine 100 units/mL: A patient-level pooled analysis of 16 randomised controlled trials
Chan, Juliana C.N., Bunnag, Pongamorn, Chan, Siew P., Tan, Iris T.I., Tsai, Shih-Tzer, Gao, Ling, Landgraf, Wolfgang
Published in Diabetes research and clinical practice (01.01.2018)
Published in Diabetes research and clinical practice (01.01.2018)
Get full text
Journal Article
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents--a randomized, prospective, crossover, open clinical trial
Hermanns, Norbert, Kulzer, Bernd, Kohlmann, Thomas, Jacob, Stephan, Landgraf, Wolfgang, Theobald, Karlheinz, Haak, Thomas
Published in Health and quality of life outcomes (09.06.2015)
Published in Health and quality of life outcomes (09.06.2015)
Get full text
Journal Article